Stocktoria
Verrica Pharmaceuticals Inc. VRCA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-06-15
Chart by TradingView
5/9
Piotroski F — financial health
-19.42
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $35.6M | $7.6M | $5.1M | $9.0M | $12.0M |
| Operating income | -$12.2M | -$65.9M | -$65.8M | -$21.3M | -$30.9M |
| Net income | -$17.9M | -$76.6M | -$67.0M | -$24.5M | -$35.1M |
| Operating cash flow | -$17.6M | -$60.9M | -$38.6M | -$18.6M | -$27.6M |
| Free cash flow | -$17.6M | -$61.0M | -$38.9M | -$19.0M | -$28.5M |
| Total assets | $47.1M | $54.1M | $81.6M | $44.7M | $80.1M |
| Total liabilities | $22.4M | $64.0M | $61.8M | $4.7M | $47.5M |
| Shareholders' equity | $24.7M | -$9.9M | $19.8M | $40.0M | $32.6M |
| Ratios | |||||
| Operating margin | -34.2% | -871.3% | -1283.4% | -235.8% | -257.6% |
| Net margin | -50.3% | -1012.1% | -1307.5% | -271.1% | -292.3% |
| FCF margin | -49.5% | -805.6% | -759.9% | -209.8% | -237.2% |
| Return on assets | -37.9% | -141.5% | -82.1% | -54.8% | -43.8% |
| Return on equity | -72.3% | 776.7% | -339.0% | -61.2% | -107.6% |
| Debt / equity | 0.00× | -3.14× | 2.17× | 0.00× | — |
| Current ratio | 2.59 | 1.76 | 4.55 | 11.31 | 1.61 |
| Revenue growth | 370.2% | 47.7% | -43.3% | -24.7% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 32,360 | $171,184 |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -19.42 (distress)
- Working capital / assets 0.554
- Retained earnings / assets -6.894
- EBIT / assets -0.259
- Equity / liabilities 1.105
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001660334 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.